Jiangzhong Pharmaceutical set to unlock third tranche of restricted shares

Jiangzhong Pharmaceutical Co., Ltd. has announced the unlocking and listing of 1,392,949 restricted shares, effective December 1, 2025. These shares represent the third release period from the company's 2021 restricted stock incentive plan, following the fulfillment of all necessary conditions. The release will increase the number of unrestricted shares by 1,392,949 while reducing the restricted shares by the same amount.

The incentive plan's initial grant was registered on November 30, 2021, involving 87 individuals and 5.734 million shares at an average price of CNY 6.62 per share. For this third release, 70 eligible employees will collectively unlock the 1,392,949 shares, which constitutes one-third of their original grant.

The company met all performance conditions for this release, including a 2024 return on invested capital of 20.48%, an average annual net profit growth rate for shareholders of 13.57% since 2020, and a 2024 R&D intensity of 4.82%.